Members of the Section have determined the CTNS mutations responsible for benign (ocular) and intermediate cystinosis, and have reviewed the worlds reported CTNS mutations. They have developed a multiplex PCR amplification method for diagnosing the presence of the 57-kb deletion present in 56% of 216 cytinosis alleles tested. The Section continues to treat over 100 patients with oral and topical (eyedrop) cysteamine. 2. In collaboration with NHGRI investigators, a new gene adjacent to CTNS was discovered. The gene, called CARKL, presumably produces a carbohydrate kinase and may distinguish cystinosis patients bearing the 57-kb deletion from nondeletion patients. It has a 1434 bp open reading frame with 7 exons encoding a 478 amino acid protein. Expression of a 3.9 kb transcript occurs prominently in liver, kidney, and pancreas. 3. The fifth patient in the world with sialuria has been characterized. This 7-year old Portuguese girl carries a single copy of a UDP-GlcNAc 2-epimerase gene containing an R266Q mutation, and the resulting enzyme is inhibited only 26% by 100 micromolar CMP-sialic acid (normal, 79%). 4. More than 95 patients with Hermansky Pudlak syndrome (HPS) have now been examined at the NIH Clinical Center, and the pulmonary, dermatologic, and ophthalmologic aspects of the disorder have been described. Members of the Section have also identified and clinically characterized two HPS patients who are compound heterozygotes for mutations in the beta-3A subunit of AP-3, an adaptor protein complex responsible for vesicular trafficking and cargo sorting. - Cystinosis, sialuria, Hermansky-Pudlak syndrome, vesicular trafficking, mutation analysis - Human Subjects

Agency
National Institute of Health (NIH)
Institute
Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
Type
Intramural Research (Z01)
Project #
1Z01HD000131-25
Application #
6290153
Study Section
Special Emphasis Panel (HDB)
Project Start
Project End
Budget Start
Budget End
Support Year
25
Fiscal Year
1999
Total Cost
Indirect Cost
City
State
Country
United States
Zip Code
Gottlieb, Emily; Ciccone, Carla; Darvish, Daniel et al. (2005) Single nucleotide polymorphisms in the dystroglycan gene do not correlate with disease severity in hereditary inclusion body myopathy. Mol Genet Metab 86:244-9
Martin, Rick A; Slaugh, Rachel; Natowicz, Marvin et al. (2003) Sialic acid storage disease of the Salla phenotype in American monozygous twin female sibs. Am J Med Genet A 120:23-7
Gahl, William A; Thoene, Jess G; Schneider, Jerry A (2002) Cystinosis. N Engl J Med 347:111-21
Kleta, Robert; Gahl, William A (2002) Cystinosis: antibodies and healthy bodies. J Am Soc Nephrol 13:2189-91
Huizing, M; Gahl, W A (2002) Disorders of vesicles of lysosomal lineage: the Hermansky-Pudlak syndromes. Curr Mol Med 2:451-67
Gahl, William A; Brantly, Mark; Troendle, James et al. (2002) Effect of pirfenidone on the pulmonary fibrosis of Hermansky-Pudlak syndrome. Mol Genet Metab 76:234-42
Kleta, Robert; Skovby, Flemming; Christensen, Ernst et al. (2002) 3-Methylglutaconic aciduria type III in a non-Iraqi-Jewish kindred: clinical and molecular findings. Mol Genet Metab 76:201-6
Huizing, Marjan; Boissy, Raymond E; Gahl, William A (2002) Hermansky-Pudlak syndrome: vesicle formation from yeast to man. Pigment Cell Res 15:405-19
Huizing, Marjan; Scher, Charles D; Strovel, Erin et al. (2002) Nonsense mutations in ADTB3A cause complete deficiency of the beta3A subunit of adaptor complex-3 and severe Hermansky-Pudlak syndrome type 2. Pediatr Res 51:150-8
Maurer-Spurej, Elisabeth; Dyker, Kate; Gahl, William A et al. (2002) A novel immunocytochemical assay for the detection of serotonin in platelets. Br J Haematol 116:604-11

Showing the most recent 10 out of 41 publications